SHALABY, SARAH
 Distribuzione geografica
Continente #
NA - Nord America 1.874
AS - Asia 363
EU - Europa 318
OC - Oceania 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.562
Nazione #
US - Stati Uniti d'America 1.871
CN - Cina 184
SG - Singapore 141
IT - Italia 136
DE - Germania 39
SE - Svezia 27
FI - Finlandia 26
IN - India 26
FR - Francia 24
GB - Regno Unito 21
IE - Irlanda 11
ES - Italia 9
NL - Olanda 9
RO - Romania 4
CA - Canada 3
PL - Polonia 3
UA - Ucraina 3
VN - Vietnam 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
AU - Australia 2
ET - Etiopia 2
HK - Hong Kong 2
RS - Serbia 2
TR - Turchia 2
BD - Bangladesh 1
BE - Belgio 1
CH - Svizzera 1
IR - Iran 1
JP - Giappone 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 2.562
Città #
Fairfield 331
Chandler 168
Woodbridge 158
Ashburn 149
Seattle 133
Houston 124
Cambridge 119
Singapore 112
Wilmington 93
Ann Arbor 81
San Diego 56
Beijing 46
Padova 37
Medford 34
Princeton 34
Des Moines 26
Pune 22
Helsinki 21
Roxbury 20
Santa Clara 18
Guangzhou 17
Boardman 14
Dearborn 11
Dublin 11
Milan 11
Nanjing 11
Shanghai 10
Hefei 8
London 7
Jinan 6
New York 6
Bologna 5
Los Angeles 5
Rome 5
Rozzano 5
Shenyang 5
Trieste 5
Lappeenranta 4
Munich 4
Nanchang 4
Naples 4
Amsterdam 3
Biella 3
Frankfurt am Main 3
Fuzhou 3
Hangzhou 3
Kilburn 3
Kunming 3
Lozzo Atestino 3
Málaga 3
Ogden 3
Phoenix 3
Pisa 3
Rizhao 3
Vinh 3
Addis Ababa 2
Anyang 2
Barcelona 2
Esslingen am Neckar 2
Forlì 2
Hebei 2
Hong Kong 2
Kharkiv 2
L’Aquila 2
Meana Sardo 2
Ningbo 2
Norwalk 2
Ospedaletto Euganeo 2
Pamplona 2
Piacenza 2
Redwood City 2
Tappahannock 2
Tianjin 2
Vienna 2
Washington 2
Weimar 2
Acton 1
Adliswil 1
Alexandria 1
Andover 1
Ankara 1
Auckland 1
Belgrade 1
Biassono 1
Boston 1
Brussels 1
Calgary 1
Campolongo 1
Changsha 1
Chaoyang 1
Charlotte 1
Chiswick 1
Chongqing 1
Clearwater 1
Dallas 1
Falkenstein 1
Fenghua 1
Foggia 1
Granada 1
Guishan 1
Totale 2.048
Nome #
Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy 151
Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals 126
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 119
A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis 118
"DAA in patients with Hepatocellular carcinoma before Liver Transplantation: are we sure is still an open issue?" 111
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 104
Management of bacterial infection in the liver transplant candidate 103
Eradication of HCV in patients awaiting liver transplantation does not increase drop-out due to HCC progression 97
Reversal of hypercoagulability in patients with HCV-related cirrhosis after treatment with direct acting antivirals 92
Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985-2014 90
Survival after the diagnosis of de novo malignancy in liver transplant recipients 88
HCV eradication is not associated with drop-out due to HCC progression in patients awaiting liver transplantation: A monocentric experience 87
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis 87
Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation 85
Endothelial damage of the portal vein is associated with Heparin-like effect in advanced stages of cirrhosis 82
Local prothrombotic state in portal venous system in cirrhosis 73
PERIPHERAL NK CELLS IN PATIENTS WITH HCV RECURRENCE AFTER LIVER TRANSPLANTATION DURING INTERFERON-FREE ANTIVIRAL THERAPY 66
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort study 62
Management of portal hypertension severe complications 57
Long-term care of transplant recipients: de novo neoplasms after liver transplantation 53
Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy 52
Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma 51
Drug induced liver injury: from pathogenesis to liver transplantation 50
Role of local endothelial alterations in the pathogenesis of portal vein thrombosis in cirrhosis 44
De novo and recurrent malignancy 42
Reply 38
Influence of hepatocellular carcinoma on platelet aggregation in cirrhosis 38
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC 38
An Essential Guide for Managing Post-Liver Transplant Patients: What Primary Care Physicians Should Know 37
Role of non-neoplastic portal vein thrombosis in the natural history of patients with cirrhosis and first diagnosis of hepatocellular carcinoma 36
Malnourished cirrhotic patient: what should we do? 36
Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis 34
Reply to "Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis" 34
Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections 33
Immune Activation, Exhaustion and Senescence Profiles as Possible Predictors of Cancer in Liver Transplanted Patients 31
New indications for liver transplantation 29
Changings and Challenges in Liver Transplantation for Nonalcoholic Fatty Liver Disease/Steatohepatitis 23
Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive review 22
Recent advances in the management of acute variceal hemorrhage 19
Clinical impact of sexual dimorphism in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) 17
Vascular liver diseases: A sex-oriented analysis of the literature 16
Erratum to “Practice variation in anastomotic leak after esophagectomy: Unravelling differences in failure to rescue” [Eur J Surg Oncol 49 (5) (May 2023) 974–982](S074879832300032X)(10.1016/j.ejso.2023.01.010) 12
Hepatic venous pressure gradient in hepatic resection for hepatocellular carcinoma 11
Ruolo prognostico della trombosi portale non neoplastica nel paziente cirrotico con epatocarcinoma 10
Profiling plasma alterations of extracellular vesicles in patients with acutely decompensated cirrhosis and bacterial infection 9
Coagulation meets senescence in NASH! 7
Sex disparity and drug-induced liver injury 5
Totale 2.625
Categoria #
all - tutte 13.791
article - articoli 12.491
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.282


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020347 0 0 0 0 49 42 69 53 57 37 22 18
2020/2021350 15 22 25 23 6 21 15 30 38 55 36 64
2021/2022533 23 31 58 27 21 69 52 37 24 29 49 113
2022/2023380 63 33 9 39 67 44 11 31 48 3 27 5
2023/2024384 34 44 45 29 34 51 41 13 20 27 20 26
2024/2025253 2 121 48 80 2 0 0 0 0 0 0 0
Totale 2.625